Profile data is unavailable for this security.
About the company
Rohto Pharmaceutical Co Ltd is a Japan-based company primarily engaged in the manufacture and sale of eye care (eye drops, eyewash), skin care (external medications, lip balm, sunscreen, functional cosmetics), oral medication (gastrointestinal medicines, herbal medicines, supplements), and other products and services (in vitro diagnostic reagents) in the health and beauty care field. The Company operates through four regional segments. The Japan segment manufactures and sells eye care, skin care, oral medication, and other products (services). The Americas segment and the Europe segment mainly manufacture and sell skin care products (services). The Asia segment mainly manufactures and sells eye care and skin care products (services), as well as oral medication products (services).
- Revenue in JPY (TTM)322.23bn
- Net income in JPY34.29bn
- Incorporated1949
- Employees9.14k
- LocationRohto Pharmaceutical Co Ltd1-8-1, Tatsumi-Nishi, Ikuno-kuOSAKA-SHI 544-8666JapanJPN
- Phone+81 667581231
- Websitehttps://www.rohto.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Towa Pharmaceutical Co Ltd | 262.18bn | 16.00bn | 146.67bn | 4.79k | 8.76 | 0.8114 | 4.01 | 0.5594 | 325.11 | 325.11 | 5,325.91 | 3,508.66 | 0.566 | 1.54 | 3.73 | 54,757,100.00 | 3.46 | 3.89 | 4.23 | 5.07 | 36.26 | 37.81 | 6.10 | 6.61 | 1.56 | 734.71 | 0.5794 | 21.52 | 13.89 | 18.65 | 17.39 | 5.53 | 46.23 | 9.73 |
| Kaken Pharmaceutical Co Ltd | 94.65bn | 12.46bn | 161.90bn | 1.13k | 11.01 | 0.942 | 10.80 | 1.71 | 333.12 | 333.12 | 2,477.35 | 3,894.02 | 0.5391 | 2.04 | 4.10 | 84,056,840.00 | 7.10 | 5.99 | 8.14 | 6.87 | 61.65 | 56.17 | 13.17 | 12.91 | 3.58 | -- | 0.0255 | 59.58 | 30.52 | 1.05 | 73.77 | -6.36 | 14.81 | 0.00 |
| Kissei Pharmaceutical Co Ltd | 89.36bn | 12.37bn | 192.22bn | 1.78k | 14.26 | 0.8264 | 11.32 | 2.15 | 289.63 | 289.63 | 2,075.97 | 4,997.78 | 0.3563 | 1.76 | 3.20 | 50,257,030.00 | 4.94 | 4.26 | 5.32 | 4.60 | 49.54 | 48.59 | 13.87 | 14.30 | 4.46 | -- | 0.0061 | 32.41 | 16.87 | 6.91 | 7.18 | 33.54 | 31.04 | 13.97 |
| Sawai Group Holdings Co Ltd | 194.21bn | 2.97bn | 219.14bn | 3.31k | 92.51 | 1.25 | 11.77 | 1.13 | 20.51 | 7.05 | 1,612.14 | 1,521.63 | 0.5378 | 1.25 | 3.64 | 58,672,810.00 | 0.823 | -0.2327 | 1.07 | -0.3187 | 29.75 | 32.95 | 1.53 | -0.475 | 0.8581 | 5.40 | 0.3751 | 191.65 | 6.88 | 0.7009 | -87.38 | -35.38 | 8.65 | 4.11 |
| Nippon Shinyaku Co Ltd | 160.65bn | 30.55bn | 228.04bn | 2.24k | 7.16 | 0.8696 | 6.22 | 1.42 | 453.52 | 453.52 | 2,384.95 | 3,732.95 | 0.5784 | 1.23 | 3.54 | 71,621,490.00 | 11.00 | 10.89 | 12.47 | 12.74 | 68.17 | 63.93 | 19.02 | 17.67 | 3.50 | -- | 0.0095 | 30.58 | 8.08 | 6.56 | 25.94 | 14.06 | 80.48 | 7.59 |
| Tsumura & Co | 180.50bn | 25.62bn | 268.35bn | 4.27k | 10.34 | 0.9037 | 6.90 | 1.49 | 338.03 | 338.03 | 2,384.03 | 3,868.60 | 0.3964 | 0.7064 | 2.60 | 42,251,170.00 | 6.05 | 5.53 | 7.76 | 6.85 | 48.90 | 49.39 | 15.27 | 14.50 | 2.35 | 20.02 | 0.2277 | 31.65 | 20.05 | 8.00 | 94.10 | 18.69 | 23.07 | 16.27 |
| Hisamitsu Pharmaceutical Co Inc | 155.49bn | 19.68bn | 309.83bn | 2.80k | 15.26 | 1.10 | 11.49 | 1.99 | 270.13 | 270.13 | 2,134.73 | 3,739.02 | 0.453 | 2.61 | 3.10 | 55,553,060.00 | 5.86 | 4.34 | 7.03 | 4.99 | 59.73 | 57.83 | 12.95 | 10.32 | 3.38 | -- | 0.0088 | 50.29 | 10.09 | 2.04 | 55.76 | 3.08 | 29.89 | 0.7127 |
| Santen Pharmaceutical Co Ltd | 293.97bn | 31.50bn | 518.58bn | 3.85k | 16.58 | 1.81 | 10.62 | 1.76 | 91.43 | 91.43 | 853.98 | 835.96 | 0.698 | 2.33 | 3.89 | 76,375,680.00 | 7.39 | 3.94 | 9.32 | 4.93 | 56.26 | 58.97 | 10.58 | 6.01 | 1.88 | -- | 0.1745 | 71.86 | -0.6494 | 4.43 | 36.09 | 8.94 | 3.61 | 5.92 |
| Rohto Pharmaceutical Co Ltd | 322.23bn | 34.29bn | 572.26bn | 9.14k | 16.17 | 2.05 | 11.56 | 1.78 | 149.82 | 149.82 | 1,408.30 | 1,180.47 | 0.7699 | 2.29 | 4.81 | 35,239,830.00 | 8.25 | 8.59 | 11.21 | 11.70 | 56.39 | 57.78 | 10.71 | 10.57 | 1.79 | -- | 0.1468 | 21.12 | 13.95 | 10.38 | 0.2263 | 15.01 | 10.42 | 22.59 |
| Sumitomo Pharma Co Ltd | 416.16bn | 18.90bn | 689.96bn | 3.83k | 36.44 | 3.91 | 16.13 | 1.66 | 47.58 | 47.58 | 1,047.49 | 443.59 | 0.5195 | 1.57 | 5.29 | 108,601,000.00 | 2.36 | -5.49 | 4.34 | -8.49 | 60.93 | 67.88 | 4.54 | -13.24 | 0.7207 | 1.30 | 0.637 | -- | 26.79 | -3.75 | 107.50 | -10.32 | -0.4856 | -- |
| Ono Pharmaceutical Co Ltd | 496.73bn | 42.93bn | 889.67bn | 4.29k | 19.52 | 1.08 | 11.91 | 1.79 | 91.39 | 91.39 | 1,057.50 | 1,644.71 | 0.4714 | 2.50 | 3.38 | 115,869,400.00 | 4.08 | 10.78 | 5.01 | 12.37 | 68.74 | 73.23 | 8.65 | 21.23 | 2.44 | 21.41 | 0.1507 | 36.33 | -3.14 | 10.73 | -60.89 | -3.47 | -18.66 | 12.20 |
| Kyowa Kirin Co Ltd | 493.24bn | 38.41bn | 1.20tn | 5.67k | 31.18 | 1.42 | 18.91 | 2.43 | 73.18 | 73.18 | 940.71 | 1,608.40 | 0.4617 | 1.80 | 3.46 | 87,006,180.00 | 3.60 | 6.37 | 4.26 | 7.25 | 72.63 | 75.13 | 7.79 | 14.65 | 2.35 | 9.22 | 0.00 | 46.38 | 12.06 | 10.14 | -26.26 | 9.71 | 37.71 | 6.67 |
| Eisai Co Ltd | 803.02bn | 50.33bn | 1.31tn | 13.51k | 25.28 | 1.53 | 14.37 | 1.64 | 178.21 | 178.21 | 2,843.39 | 2,936.77 | 0.5675 | 0.8215 | 3.78 | 59,456,680.00 | 3.67 | 3.81 | 5.04 | 5.14 | 78.62 | 77.47 | 6.46 | 6.44 | 1.30 | -- | 0.2187 | 98.01 | 6.42 | 2.56 | 9.49 | -17.54 | -14.48 | 0.00 |
Data as of Oct 17 2025. Currency figures normalised to Rohto Pharmaceutical Co Ltd's reporting currency: Japanese Yen JPY
